News & Videos - 2INVEST AGNA O.N. - English

DGAP-News: 4basebio AG / Key word(s): Statement/Offer 4basebio AG: 4basebio comments on the takeover bid of Sparta AG 14.09.2020 / 16:00 The issuer is solely responsible for the content of this announcement. Heidelberg, and Cambridge, United Kingdom, 14 September 2020 - In a document available on the Company's website https://investors.4basebio.com/investment-case/sparta-offer/ (German language only) , 4basebio AG (Frankfurt: 4BSB; ISIN: DE000A2YN801; Prime Standard) comments in detail on the...

DGAP-Ad-hoc: 4basebio AG / Key word(s): Strategic Company Decision 4basebio AG announces process for spin-off and separate stock market listing for its DNA business 17-Aug-2020 / 11:32 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. / 4basebio AG announces process for spin-off and separate stock market listing for its DNA...

DGAP-News: 4basebio AG / Key word(s): Half Year Results 4basebio AG: 4basebio AG reports first six months of 2020 financial results 13.08.2020 / 07:30 The issuer is solely responsible for the content of this announcement. - 4basebio reports strong H1 profit - Cash balances and liquid resources of EUR 100 million - Ongoing progress and investment in DNA manufacturing capabilities - Treasury shares held in Q1 following share buyback now cancelled Conference call for investors and analysts to be...

DGAP-News: 4basebio AG / Key word(s): Offer 4basebio AG: 4basebio informs about takeover bid by Sparta AG 28.07.2020 / 07:30 The issuer is solely responsible for the content of this announcement. Heidelberg, Germany and Cambridge, UK, 28 July, 2020 - 4basebio AG (Frankfurt: 4BSB; ISIN: DE000A2YN801; Prime Standard) announces that its investor Sparta AG intends to submit a takeover bid for the company's shares. According to an announcement Sparta published on July 27, 2020, Sparta has decided to...

DGAP-News: 4basebio AG / Key word(s): AGM/EGM 4basebio AG: 4basebio reports on results of Annual General Meeting 2020 17.06.2020 / 17:30 The issuer is solely responsible for the content of this announcement. Heidelberg, Germany and Cambridge, UK, 17 June 2020 - 4basebio AG (Frankfurt: 4BSB; ISIN: DE000A2YN801; Prime Standard) announces the results of the Annual General Meeting (AGM) held today on June 17, 2020. The shareholders approved all resolutions proposed by the Management Board and...

DGAP-News: 4basebio AG / Key word(s): Alliance 4basebio AG: Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio's contribution receives funding from 'la Caixa' Banking Foundation 20.05.2020 / 16:00 The issuer is solely responsible for the content of this announcement. Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio's contribution receives funding from "la Caixa" Banking Foundation Heidelberg, Germany and Cambridge, UK, 20 May 2020 - 4basebio AG (Frankfurt: 4BSB;...

DGAP-News: 4basebio AG / Key word(s): Quarterly / Interim Statement 4basebio AG: 4basebio AG reports first quarter 2020 financial results 14.05.2020 / 07:30 The issuer is solely responsible for the content of this announcement. 4basebio AG reports first quarter 2020 financial results - 4basebio reports strong Q1 net profit following Abcam transaction - Significant cash position enables focus on further strategy - Successful completion of 10% share buyback - Continued development of DNA...

DGAP-News: 4basebio AG / Key word(s): Annual Results 4basebio AG: 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financial Guidance Met 24.04.2020 / 07:30 The issuer is solely responsible for the content of this announcement. 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financial Guidance Met Conference call to be held today, 24 April 2020, 3:00pm CET/2:00pm BST - 4basebio meets full year financial guidance: - Revenues for 2019 of EUR 15.7 million...

DGAP-News: 4basebio AG / Key word(s): Alliance 4basebio AG: 4basebio provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection 22.04.2020 / 10:30 The issuer is solely responsible for the content of this announcement. 4basebio provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection Heidelberg, Germany and Cambridge, UK, 22 April 2020 - 4basebio AG (Frankfurt: 4BSB; ISIN:...

DGAP-Ad-hoc: 4basebio AG / Key word(s): Corporate Action 4basebio AG: 4basebio AG resolves on capital reduction by way of redemption of approx. 5.2 million treasury shares in accordance with the authorizing resolution of the general meeting 20-Apr-2020 / 19:19 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. 4basebio AG...

DGAP-News: 4basebio AG / Key word(s): Share Buyback 4basebio AG: 4basebio AG announces allotment ratio and final number of shares for the share buy back 21.02.2020 / 14:00 The issuer is solely responsible for the content of this announcement. Heidelberg, Germany, and Cambridge, UK, 21 February 2020 - 4basebio AG (formerly Expedeon AG) (Frankfurt: 4BSB; ISIN: DE000A2YN801; Prime Standard) today announces the allotment ratio and the final number of shares for the announced share buyback program....

DGAP-News: 4basebio AG / Key word(s): Share Buyback 4basebio AG: 4basebio AG announces results of the public share buyback offerand final purchase price for the share buy back (news with additional features) 14.02.2020 / 15:00 The issuer is solely responsible for the content of this announcement. Press Release 14 February 2020 4basebio AG announces results of the public share buyback offer and final purchase price for the share buy back Heidelberg, Germany, and Cambridge, UK, 14 February 2020 -...

DGAP-News: 4basebio AG / Key word(s): Share Buyback 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares (news with additional features) 10.02.2020 / 11:45 The issuer is solely responsible for the content of this announcement. Press Release 10 February 2020 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares Heidelberg, Germany, and Cambridge, UK, 10 February 2020 - The...

DGAP-Ad-hoc: 4basebio AG / Key word(s): Share Buyback 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares 10-Feb-2020 / 11:30 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad hoc Release according to Art. 17 Market Abuse Regulation 4basebio AG decides to...

DGAP-News: 4basebio AG / Key word(s): Share Buyback 4basebio AG: 4basebio AG decides to buy back 2 million treasury shares (news with additional features) 21.01.2020 / 14:00 The issuer is solely responsible for the content of this announcement. Press Release 21 January 2020 4basebio AG decides to buy back 2 million treasury shares - Voluntary public share buyback offer against cash payment in a purchase price range of EUR 1.60 to EUR 1.85 per share - Repurchased shares to be retained in treasury...

DGAP-Ad-hoc: 4basebio AG / Key word(s): Share Buyback 4basebio AG: 4basebio AG decides to buy back 2 million treasury shares for further use in accordance with the authorizing resolution 21-Jan-2020 / 12:53 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. / 4basebio AG decides to buy back 2 million treasury shares for...

DGAP-News: 4basebio AG / Key word(s): Miscellaneous 4basebio AG: Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB (news with additional features) 21.01.2020 / 07:30 The issuer is solely responsible for the content of this announcement. PRESS RELEASE 21 January 2020 Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB - Share is now traded under new ticker symbol 4BSB. WKN and ISIN remain. - New name reflects repositioning on DNA...

DGAP-News: Expedeon AG / Key word(s): Disposal Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction (news with additional features) 02.01.2020 / 07:30 The issuer is solely responsible for the content of this announcement. PRESS RELEASE 02 January 2020 Expedeon AG and Abcam plc close EUR 120 million transaction  Closing triggers payment of EUR 120 million  Expedeon AG plans name change to 4basebio AG and change of ticker to 4BSB  Future focus on DNA manufacturing and...

DGAP-News: Expedeon AG / Key word(s): Acquisition Expedeon AG: Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG (news with additional features) 19.12.2019 / 19:30 The issuer is solely responsible for the content of this announcement. PRESS RELEASE 19 December 2019 Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG - 120 million Euro transaction approved - Future focus on DNA...

DGAP-News: Expedeon AG / Key word(s): Conference Expedeon AG: Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main (news with additional features) 21.11.2019 / 07:30 The issuer is solely responsible for the content of this announcement. Press release 21 November 2019 / Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main Heidelberg, Germany and Cambridge, UK, 21 November 2019 - Expedeon AG (Frankfurt: EXNN; ISIN: DE000A2YN801; Prime Standard) today...